A carregar...
Myeloid Cells as Clinical Biomarkers for Immune Checkpoint Blockade
Immune checkpoint inhibitors are becoming standard treatments in several cancer types, profoundly changing the prognosis of a fraction of patients. Currently, many efforts are being made to predict responders and to understand how to overcome resistance in non-responders. Given the crucial role of m...
Na minha lista:
| Publicado no: | Front Immunol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7393010/ https://ncbi.nlm.nih.gov/pubmed/32793228 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.01590 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|